Rocrose FCM – Ferric Carboxymaltose Injection

Rocrose FCM, proudly manufactured by BIO AXA LTD, offers a powerful solution for iron deficiency anemia in adults. This sterile, aqueous complex of polynuclear iron (III)-hydroxide with carboxymaltose comes in a single-dose vial, providing 500 mg of elemental iron in 10 mL for intravenous use. Importantly, this product is ideal for patients who struggle with oral iron or have specific medical conditions.

Who Can Benefit from Rocrose FCM?

Rocrose FCM effectively treats iron deficiency anemia in adults under the following conditions:

• Patients who cannot tolerate oral iron or see poor results from it.
• Individuals with non-dialysis dependent chronic kidney disease.
• Those receiving hemodialysis and experiencing iron deficiency anemia.

How to Use Rocrose FCM

Healthcare professionals administer Rocrose FCM intravenously in a clinical setting. First, they calculate the dose based on your weight and hemoglobin levels. Typically, the total dose reaches up to 1000 mg of iron per course, split into two doses at least 7 days apart. After administration, doctors monitor patients for at least 30 minutes to ensure safety and detect any reactions early.

Key Features and Benefits

• Rapid Iron Replenishment: Rocrose FCM quickly boosts iron levels, helping patients feel better faster.
• Targeted Treatment: It works well for those who cannot use oral iron or have specific health conditions like chronic kidney disease.
• Single-Dose Convenience: Each vial contains 500 mg of iron in 10 mL, making it easy to manage in a clinical setting.

Storage Instructions

Store Rocrose FCM at 20°C to 25°C (68°F to 77°F). You can allow brief temperature changes between 15°C to 30°C (59°F to 86°F). However, never freeze the product to maintain its effectiveness.

Important Safety Information

While Rocrose FCM is highly effective, it comes with some precautions:

• Hypersensitivity Risks: Rarely, serious allergic reactions like anaphylaxis may occur. Therefore, doctors observe patients closely after each dose.
• Side Effects: Some patients may experience nausea, high blood pressure, flushing, injection site reactions, low phosphate levels, or dizziness.
• Contraindications: Avoid using Rocrose FCM if you have a known allergy to ferric carboxymaltose or any ingredient in the formula.

Why Choose Rocrose FCM?

Rocrose FCM stands out as a reliable choice for managing iron deficiency anemia. Its intravenous delivery ensures quick absorption, making it a go-to option for patients with specific needs. Moreover, the product’s packaging features red blood cell graphics, visually emphasizing its role in improving blood health—an added touch that highlights its purpose.

For healthcare providers and pharmacies, Rocrose FCM offers a trusted solution to support patients in need of iron therapy. Ensure proper administration by trained professionals to maximize safety and effectiveness.

Key Points